[Transmasculine people: Gender affirming hormonal therapy, sexual and reproductive health prevention and care, a medical review and follow-up suggestions]
- PMID: 39097191
- DOI: 10.1016/j.gofs.2024.06.004
[Transmasculine people: Gender affirming hormonal therapy, sexual and reproductive health prevention and care, a medical review and follow-up suggestions]
Abstract
Transmasculine individuals have a poor access to health care, mostly regarding the sexual and reproductive health. Despite a lack of official guidelines, they need a gynecological follow-up, the aim of this review was to describe it. The present study involved an exhaustive search of MEDLINE, 68 articles were included to analyze the impact of hormonal therapy, prevention, and care regarding sexual and reproductive health of transmasculine individuals. Despite a lack of solid data, the global literature agrees that transmasculine individuals require sexual and reproductive health care. Care must be adapted to each pathway and may be impacted by gender-affirming care. The cancer risk does not seem to be increased in this population, particularly in relation to hormonal therapy. Prevention programs do not differ from those offered to cis women in the absence of gender-affirming surgeries. Transmasculine individuals require follow-up and care adapted to their needs and their pathways. Healthcare professionals must be trained to provide such care.
Keywords: Gynecology; Gynécologie; Homme trans; Personne transmasculine; Santé sexuelle et reproductive; Sexual and reproductive health; Transgender man; Transmasculine people.
Copyright © 2024 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Contraception across the transmasculine spectrum.Am J Obstet Gynecol. 2020 Feb;222(2):134-143. doi: 10.1016/j.ajog.2019.07.043. Epub 2019 Aug 5. Am J Obstet Gynecol. 2020. PMID: 31394072 Review.
-
HIV prevalence among transmasculine individuals at a New York City Community Health Centre: a cross-sectional study.J Int AIDS Soc. 2022 Oct;25 Suppl 5(Suppl 5):e25981. doi: 10.1002/jia2.25981. J Int AIDS Soc. 2022. PMID: 36225145 Free PMC article.
-
The effect of testosterone on ovulatory function in transmasculine individuals.Am J Obstet Gynecol. 2020 Aug;223(2):229.e1-229.e8. doi: 10.1016/j.ajog.2020.01.059. Epub 2020 Feb 8. Am J Obstet Gynecol. 2020. PMID: 32044312 Free PMC article.
-
Are cisnormative surveys adequate to assess sexual well-being in trans men post-genital gender-affirming surgery?Sex Med Rev. 2024 Sep 25;12(4):630-637. doi: 10.1093/sxmrev/qeae023. Sex Med Rev. 2024. PMID: 38651588
-
Health and Access to Gender-Affirming Care During COVID-19: Experiences of transmasculine individuals and men assigned female sex at birth.Am J Mens Health. 2021 Nov-Dec;15(6):15579883211062681. doi: 10.1177/15579883211062681. Am J Mens Health. 2021. PMID: 34861796 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical